VanEck Genomics and Healthcare Innovators UCITS ETF
CURE.DE
#3262
ETF rank
โ‚ฌ11.9 M
Marketcap
๐Ÿ‡ช๐Ÿ‡บ EU
Market
18,04ย โ‚ฌ
Share price
-1.12%
Change (1 day)
4.86%
Change (1 year)

Expense ratio and fees for VanEck Genomics and Healthcare Innovators UCITS ETF (CURE.DE)

Total Expense Ratio

Total Expense Ratio as of June 2026: 0.35%